Lifetech KONAR MFO Post-Market Clinical Follow-Up Study

Status Completed

Clinical Trial Summary

The purpose of the study is to collect real-world data on patient outcomes and evaluate the procedural success and performance of the Lifetech KONAR-MF™ VSD Occluder for patients with ventricular septal defect (VSD).

Clinical Trial Description

This is a non-randomized prospective post-marketing clinical follow-up study (PMCFS) in order to evaluate the feasibility and safety of the Lifetech KONAR-MF™ VSD Occluder device used for patients with ventricular septal defect. The implantation should be performed in accordance with the instructions for use (IFU). ;

Study Design

Related Conditions & MeSH terms

Heart Septal Defects, Ventricular
Ventricular Septal Defect

Clinical Trial Details

NCT number	NCT04417712
Study type	Observational
Source	Lifetech Scientific (Shenzhen) Co., Ltd.
Contact
Status	Completed
Phase
Start date	December 4, 2019
Completion date	June 30, 2023

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT03684161` - Cardiopulmonary Function in Adults Born With a Ventricular Septal Defect
Completed	`NCT01120964` - Intravenous L-Citrulline to Treat Children Undergoing Heart Bypass Surgery : Revised Protocol	Phase 1/Phase 2
Completed	`NCT02914652` - The Cardiopulmonary Effect of Inhaled Beta-2-agonists on Adult Patients Born With Ventricular Septum Defects.	Phase 4
Recruiting	`NCT05939713` - Cera™ VSD Occluder Post Market Clinical Follow-up
Recruiting	`NCT05688670` - Regional Anesthesia Following Pediatric Cardiac Surgery	Phase 4
Completed	`NCT02138435` - Longterm Outcome After Ventricular Septal Defect Closure	N/A
Not yet recruiting	`NCT06298344` - The Role of Thiamine After Transcatheter Closure in Children With Left-to-Right Shunt Congenital Heart Disease	Early Phase 1
Recruiting	`NCT05253209` - A Study Evaluating the Efficacy and Safety of IV L-Citrulline for the Prevention of Clinical Sequelae of Acute Lung Injury Induced by Cardiopulmonary Bypass in Pediatric Patients Undergoing Surgery for Congenital Heart Defects	Phase 3
Completed	`NCT00556361` - Use of Ketamine Prior to Cardiopulmonary Bypass in Children	Phase 2
Completed	`NCT05200910` - The Effect of Transcatheter VSD Closure on Children's Appetite, Hormones and Growth
Recruiting	`NCT03127748` - Cardiac Function After Transcatheter VSD Closure	N/A
Enrolling by invitation	`NCT06214182` - Immune Heterogeneity Before and After Cardiopulmonary Bypass in Children
Active, not recruiting	`NCT04667455` - Improving Care for Children With Congenital Heart Disease.	N/A
Completed	`NCT01313832` - The Effect of Remote Ischemic Preconditioning on the Ischemic Reperfusion Injury in Infants With Ventricular Septal Defect and Pulmonary Hypertension	N/A
Active, not recruiting	`NCT04017975` - Optical Tissue Identification for Myocardial Architecture	Phase 2
Completed	`NCT01915277` - A Phase I Study of Dexmedetomidine Bolus and Infusion in Corrective Infant Cardiac Surgery: Safety and Pharmacokinetics	Phase 1
Recruiting	`NCT03941691` - A Trial to Evaluate the Safety and Efficacy of a Fully Degradable Ventricular Septal Defect (VSD) Closure	N/A
Completed	`NCT04859036` - The Effect of Transcatheter Ventricular Septal Defect Closure on Heart Rate Variability Parameters